Free Trial

MariMed Q3 2023 Earnings Report

MariMed logo
$0.09 -0.01 (-6.00%)
As of 03:58 PM Eastern

MariMed EPS Results

Actual EPS
-$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

MariMed Revenue Results

Actual Revenue
$38.80 million
Expected Revenue
$38.70 million
Beat/Miss
Beat by +$100.00 thousand
YoY Revenue Growth
N/A

MariMed Announcement Details

Quarter
Q3 2023
Time
N/A
Remove Ads

MariMed Earnings Headlines

Marimed launches Nature’s Heritage Flower in Illinois
MariMed Launches Nature's Heritage™ Flower in Illinois
Brace Yourself for Jeff Bezos’ “Amazon Helios”
Jeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical technology that could change society forever and make early investors rich.
MariMed Inc. (OTCMKTS:MRMD) Short Interest Down 63.1% in March
See More MariMed Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like MariMed? Sign up for Earnings360's daily newsletter to receive timely earnings updates on MariMed and other key companies, straight to your email.

About MariMed

MariMed (OTCMKTS:MRMD) engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature's Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby's Baked brand; and drink mix under Vibations brand. It also offers chewable cannabis-infused mint tablet under the brand Kalm Fusion; and flower, vapes, and edibles under InHouse brand. In addition, the company provides supplement, nutrient-infused fruit chews under Betty's Eddies brand and ice creams under Emack & Bolio's brand. The company licenses its brands. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.

View MariMed Profile

More Earnings Resources from MarketBeat